- In Israel, Widespread Vaccination Slashes Severe COVID Cases in Older Patients
- Mental Health ‘Epidemic’ Threatens Communities of Color Amid COVID-19
- Expert Panel Set to Consider Approval of J&J COVID Vaccine
- Health Highlights: Feb. 26, 2021
- Pandemic Is Hitting Hospitals Hard, Including Their Bottom Line
- Common Antidepressants Won’t Raise Risk for Bleeding Strokes: Study
- Hair Salon Talk Can Spread COVID, But Face Shields Cut the Danger
- Menthols Lured 10 Million Americans to Smoking Since 1980: Study
- As Climate Change Lengthens Allergy Season, Pollen Travels Farther
- Masks Vital to Stopping COVID at Gyms, Studies Show
Clinical Trials Update: June 21, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Chronic Pain
This study will evaluate a drug to treat moderate-to-severe chronic pain. Candidates must be aged 18 to 75.
The research site is in Phoenix, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/pain.aspx.
—–
Rheumatoid Arthritis
This study will evaluate an investigational drug for rheumatoid arthritis. Candidates must have active RA and have not fully responded to RA treatment.
The research site is in Albuquerque, N.M.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/arthritis.aspx.
—–
Tinnitus
This study will compare the drug Neramexane to a placebo for people with tinnitus. The study will last about six months with nine office visits, and participants may be compensated for time and travel up to $675.
The research site is in Plano, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/tinnitus.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
